Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : EQUIDYNE CORP: IJX (AMEX) -- Ignore unavailable to you. Want to Upgrade?

To: Skywatcher who wrote (158)	5/18/2001 9:16:36 PM
From: dgrebles	Read Replies (11) \| Respond to of 179

Chris: I have always had concerns about inhaling insulin. Nice in theory, but too much to lose if something goes wrong. You can always find a new site to inject into. Besides, I understand they have only developed a short acting insulin. That means you would still have to inject longer acting in order to maintain good control. Go IJX !!!

To: Skywatcher who wrote (158)	7/3/2001 11:42:11 AM
From: Skywatcher	Respond to of 179

We have more serious IR publicity on this good news as promised by the company. I hope this opens new markets for the product. Equidyne Says FDA OK's Needle-Free Shot LOS ANGELES (Reuters) - Equidyne Corp. (AMEX:IJX - news) said on Monday that its disposable system using ``jet injection'' instead of a needle to deliver medications has been approved by the U.S. Food and Drug Administration (news - web sites). The San Diego company's shares were up 28 cents, or more than 16 percent, at $1.99 in afternoon trading on the American Stock Exchange after reaching as high as $2.14 earlier in the day. The company said in a statement that it was in talks with pharmaceutical manufacturers and regulatory agencies about possible applications for the product, called Injex. Unlike earlier versions of the company's systems consisting of a multiple-use stainless steel injector and a single-use disposable medication ampule, the new disposable Injex combines an ampule with a device that transmits drugs through the skin via a thin, high-pressure stream of liquid that is used once and then thrown away. Equidyne describes its needle-free injector as a compact, uncomplicated device that delivers a virtually painless injection through the skin in a fraction of a second, eliminating the risk of disease from needle stick as well as the problems and cost of disposal. The company said potential applications include short-term injectable drug therapies administered by patients at home, as well as some subcutaneous vaccines. Equidyne said it will start production of the product in the United States when it signs a license and supply agreement. chris